Mastek Ltd

The transcript from Mastek Limited's call does not mention any current or planned fundraising through debt or equity. Key points related to the company's financial plans are: - No mention of raising funds through debt or equity in the discussed period. - Focus is on driving operational efficiency to improve margins and profitability. - The company is leveraging organic growth in core businesses in the U.K., Europe, and Oracle-related services. - Emphasis on internally building capabilities, especially around Data & AI, rather than external fundraising. - Cash and cash equivalents have increased to INR 622 crores, indicating strong cash generation and no immediate need for external capital. - Management discusses managing near-term uncertainties but does not indicate plans for additional capital raise. Therefore, based on the transcript provided, there is no indication of current or future fundraising through debt or equity.

- Mastek is actively investing in building Data & AI capabilities, expanding the team by adding 50-100 people quarterly, focusing on reskilling and new additions. - The company is making strategic investments in asset accelerators by collaborating with and acquiring platforms from startups to boost technology adoption and solution building. - There is a focus on investments in new technology adoption, especially around AI, with ongoing proof of concepts (POCs) and pilots with customers. - Mastek aims to drive operational efficiency through AI adoption in delivery, targeting 15-20% efficiency gains. - In the U.S., there is a strategic reset with disproportionate investment in Data & AI capabilities aligned closely with client demand. - Investments in Oracle-related businesses continue, including leveraging Oracle's AI initiatives and partnerships like the Stargate JV, albeit with no immediate visible impact this quarter.

- FY'26 is seen as an important year with focus on core UK & Europe and Oracle businesses as key growth levers. - U.S. business is being reset to align more with Data & AI, expecting growth in these areas. - Data & AI is expected to be the fastest-growing area, with the team expanding rapidly, including new hires and reskilling. - UK healthcare (especially NHS) business expects significant growth, including over 100% YoY growth in FY'25 continuing into FY'26. - Secured government services (SGS) in the UK has a healthy backlog and is expected to grow via new projects. - Oracle business in sectors like healthcare, manufacturing & utilities is growing strongly, particularly in the U.S. - Although near-term macroeconomic uncertainty exists, management expects continued healthy revenue growth and operational efficiency improvements in FY'26. - 12-month order backlog growth is about 7-8% YoY (adjusted for timing), supporting positive revenue outlook.

- FY'26 is seen as an important year with focus on core UK & Europe and Oracle business as key growth levers. - Resetting US business to align more with Data & AI for integrated growth. - Operational efficiency drive targeting 15-20% improvement via AI adoption and organization simplification aimed at driving margin expansion. - Near-term uncertainty in macroeconomics acknowledged, but optimistic about growth trajectory. - UK business, especially healthcare and secured government services, expected to continue healthy growth. - AI and Data capabilities across sectors and geographies anticipated to drive long-term growth. - EBITDA margin guidance remains around 17%-19% range by end of FY'26 after corrections. - Expectation to regain healthy gross margin rates as newer data & AI businesses mature and mix improves. - Overall, profitable growth and margin improvement targeted amid cautious optimism.

- The 12-month order backlog for FY'25 grew by a modest 1.7% year-on-year. - There was approximately $15 million in Annual Contract Value (ACV) contracts closed in early April, not included in the backlog numbers. - Including this $15 million, the effective 12-month backlog growth is around 7-8% year-on-year and approximately 12% quarter-on-quarter. - The backlog reflects timings of deal closings and some mismatch with outlook, but overall trend is positive. - The company is securing long-term contracts providing steady runways, especially with existing customers like Home Office. - Near-term macroeconomic uncertainties are being closely monitored, but current order book remains strong. - Growth continues especially in U.K. healthcare and secured government services sectors.